MediPharm Labs Corp.
TSXLABS filed its Q1 2026 earnings this morning, and the headline number is the one the company has been working toward: positive adjusted EBITDA. That milestone — combined with a month that saw the stock climb 23% before a modest pullback this week — frames this as a genuine inflection moment for a cannabis-sector name that has spent years restructuring toward profitability. Revenue…
Snapshot as of 28 Jun 2026
LABS filed its Q1 2026 earnings this morning, and the headline number is the one the company has been working toward: positive adjusted EBITDA. That milestone — combined with a month that saw the stock climb 23% before…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LABS — free to start on ORTEX.
Sign up for free →Open LABS on ORTEX